Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
Por um escritor misterioso
Descrição
American Thyroid Association - Our look at the STAGO trial: What's
Rosuvastatin in the Primary Prevention of Cardiovascular Disease
Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO
High Serum Cholesterol Is a Novel Risk Factor for Graves
Management of Thyroid Eye Disease: A Consensus Statement by the
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
Recent advances in graves ophthalmopathy medical therapy: a
Rosuvastatin in the Primary Prevention of Cardiovascular Disease
PDF) Management of Thyroid Eye Disease: A Consensus Statement by
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy
Graves Disease: Practice Essentials, Pathophysiology, Epidemiology
Sex-specific risk factors associated with graves' orbitopathy in
Management of thyroid eye disease: a Consensus Statement by the
Effect of dapagliflozin on the rate of decline in kidney function
de
por adulto (o preço varia de acordo com o tamanho do grupo)
